What are key active ingredients in effective pediatric complex care programs? Over the past 2 decades, these programs have increasingly arisen. The landmark report by Mosquera and colleagues1 of a randomized clinical trial of their complex care program found that patients assigned to the intervention arm experienced substantial improvements in various outcome measures, including reduced hospitalizations and hospital days. However, these findings, compelling and consistent with other reports of positive effect,2-6 do contrast with reports of other programs that have demonstrated negative, negligible, or mixed effect.7-9
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Feudtner C, Hogan AK. Identifying and Improving the Active Ingredients in Pediatric Complex Care. JAMA Pediatr. 2021;175(1):e205042. doi:10.1001/jamapediatrics.2020.5042
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: